Sex differences in serious adverse drug reactions in patients receiving immunotherapy, targeted therapy, or chemotherapy: a disproportionality analysis of the VigiBase(R).

HOME
>
論文・技術情報
>
Sex differences in serious adverse drug reactions in patients receiving immunotherapy, targeted therapy, or chemotherapy: a disproportionality analysis of the VigiBase(R).

アブストラクト
ジャーナル名	European journal of clinical pharmacology
Pubmed追加日	2022/5/14
投稿者	Wabont, Guillaume; Bergeron, Sandrine; Gautier, Sophie; Barus, Romain
組織名	Valenciennes hospital center, 59300, Valenciennes, France.;wabont.guillaume@gmail.com.;Lille University Hospital, 59000, Lille, France.;Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition,;Lille, 59000, France.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/35562621/